دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of contents
doi : 10.1016/S0190-9622(24)00172-5
Volume 91, Issue 1, July 2024, Pages A4-A8, A17-A19, A24-A27
Information for readers
doi : 10.1016/S0190-9622(24)00173-7
Volume 91, Issue 1, July 2024, Page A28
JAAD Case Reports article list
doi : 10.1016/S0190-9622(24)00174-9
Volume 91, Issue 1, July 2024, Pages A29-A31
Journal based CME instructions and information
doi : 10.1016/S0190-9622(24)00175-0
Volume 91, Issue 1, July 2024, Page A32
Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part I. Clinical overview and pathophysiology
Hannah J. Anderson MD, Simo Huang MD, Jason B. Lee MD
doi : 10.1016/j.jaad.2023.08.020
Volume 91, Issue 1, July 2024, Pages 1-10
Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part II. Diagnosis and management
Simo Huang MD, Hannah J. Anderson MD, Jason B. Lee MD
doi : 10.1016/j.jaad.2023.08.084
Volume 91, Issue 1, July 2024, Pages 13-22
Primum non nocere
Dirk M. Elston MD
doi : 10.1016/j.jaad.2023.05.010
Volume 91, Issue 1, July 2024, Page 25
This Month in JAAD: July 2024
Dirk M. Elston MD
doi : 10.1016/j.jaad.2024.04.035
Volume 91, Issue 1, July 2024, Page 26
This month in JAAD Case Reports: July 2024: Roflumilast, Ruxolitinib, and a New Editor
Brett Sloan MD
doi : 10.1016/j.jaad.2024.05.001
Volume 91, Issue 1, July 2024, Page 27
This Month in JAAD International: July 2024
Jonathan Kantor MD, MSc, MSCE
doi : 10.1016/j.jaad.2024.05.009
Volume 91, Issue 1, July 2024, Page 28
Weighing in on glucagon-like peptide-1 receptor agonists in dermatology
Warren R. Heymann MD
doi : 10.1016/j.jaad.2024.04.044
Volume 91, Issue 1, July 2024, Pages 29-30
Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective database
Rachita Pandya BA a b, Julianne Kleitsch BA a b, Darosa Lim MD a b, Victoria P. Werth MD a b
doi : 10.1016/j.jaad.2024.02.007
Volume 91, Issue 1, July 2024, Pages 31-36
Reticulated livedoid skin patterns after soft-tissue filler–related vascular adverse events
Leonie W. Schelke MD, PhD a, Peter J. Velthuis MD, PhD a, Ali Mojallal MD, PhD b, Guillaume Henry MD b, Stefan O.P. Hofer MD, PhD c, Sebastian C. Cotofana MD, PhD a d e
doi : 10.1016/j.jaad.2024.02.008
Volume 91, Issue 1, July 2024, Pages 37-42
JAADÂ Game Changer: Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: A prospective open study and review of the literature
Faramarz Samie MD, PhD
doi : 10.1016/j.jaad.2023.09.041
Volume 91, Issue 1, July 2024, Page 42
Negative impact of comorbidities on all-cause mortality of patients with psoriasis is partially alleviated by biologic treatment: A real-world case-control study
Saba Riaz MD, BSc a, Sepideh Emam PhD a, Ting Wang MSc b, Robert Gniadecki MD, PhD, DMSci a
doi : 10.1016/j.jaad.2024.01.078
Volume 91, Issue 1, July 2024, Pages 43-50
Real-life practice of reflectance confocal microscopy in France: A prospective multicenter study
Marion Stefanski MD a b, Aurore Le Guern MD b, Laetitia Visseaux MD c, Marine Ehret MD d, Michel Colomb MD a, Géraldine Jeudy MD e, Florence Le Duff MD f, Morgane Vourc'h MD g, Barouyr Baroudjian MD h, Rosa Perea-Villacorta MD i, Charlotte Bernigaud MD j, Stéphanie Mallet MD k, Laurène Norberciak MSc l, Sébastien Debarbieux MD m, Jean-Luc Perrot MD, PhD n, Florent Grange MD, PhD o, Philippe Modiano MD, PhD b, Jilliana Monnier MD k, Philippe Bahadoran MD, PhD f, Groupe d'imagerie cutanée non-invasive de la Société Française de dermatologie
doi : 10.1016/j.jaad.2024.01.079
Volume 91, Issue 1, July 2024, Pages 51-56
Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: A cross sectional study
Lea Nymand MSc a, Lars Erik Kristensen CSO, MD, PhD b, Simon Francis Thomsen MD, PhD, DMSc a c, Jacob P. Thyssen MD, PhD, DMSc a, Alexander Egeberg MD, PhD, DMSc a
doi : 10.1016/j.jaad.2024.02.026
Volume 91, Issue 1, July 2024, Pages 57-63
Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis – results from a randomized controlled trial (PSORRO)
Mette Gyldenløve MD, PhD a b, Jennifer Astrup Sørensen MD c, Simon Fage MD d, Howraman Meteran PhD e f, Lone Skov DMSc a b, Claus Zachariae DMSc a b, Filip Krag Knop PhD b g h, Mia-Louise Nielsen PhD c, Alexander Egeberg DMSc b c
doi : 10.1016/j.jaad.2024.02.036
Volume 91, Issue 1, July 2024, Pages 64-71
Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials
Andrew Blauvelt MD, MBA a, April Armstrong MD, MPH b, Joseph F. Merola MD, MMSc c, Bruce Strober MD, PhD d e, Dirk de Cuyper MD f, Luke Peterson MS g, Owen Davies MBA, PhD h, Jeffrey L. Stark MD i, Mark Lebwohl MD j
doi : 10.1016/j.jaad.2024.02.039
Volume 91, Issue 1, July 2024, Pages 72-81
Autoimmune blistering disorders and cardiovascular risks: A population-based cohort study
Kasper Bonnesen MD, PhD a b, Christian F.B. Poulsen MD, PhD c d e f, Sigrun A.J. Schmidt MD, PhD a b g, Henrik T. Sørensen MD, PhD, DMSc, DSc a b, Morten Schmidt MD, PhD, DMSc a b c d
doi : 10.1016/j.jaad.2024.02.052
Volume 91, Issue 1, July 2024, Pages 82-90
JAADÂ Game Changer: Risk of new-onset inflammatory bowel disease among patients with acne vulgaris exposed to isotretinoin
Robert T. Brodell MD
doi : 10.1016/j.jaad.2023.09.042
Volume 91, Issue 1, July 2024, Page 90
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study
Kurt Gebauer MBBS a b, Lynda Spelman MBBS c d, Paul S. Yamauchi MD, PhD e, Jerry Bagel MD f, Tushar Nishandar MD g, Michael Crane PhD h, Iris Kopeloff MD h 1, Mudgal Kothekar MD, MBBS i, Siu-Long Yao PhD h, Howard L. Sofen MD e
doi : 10.1016/j.jaad.2024.03.025
Volume 91, Issue 1, July 2024, Pages 91-99
No impact of immunomodulatory treatments on SARS-CoV-2 (COVID-19) vaccine outcomes: A cross-sectional analysis of biologic and small molecule inhibitors used for psoriasis and hidradenitis suppurativa patients from the Epic Cosmos database
Bella R. Lee BS a, Autumn R. Brostek BA a, Benjamin H. Kaffenberger MD, MS b
doi : 10.1016/j.jaad.2024.03.004
Volume 91, Issue 1, July 2024, Pages 100-102
Ambient UV radiation is associated with cutaneous angiosarcoma incidence in the United States, 1992 to 2020
Emmanuel Ike BSE a b, Jim Z. Mai MD, PhD a, Michael R. Sargen MD a, Sara J. Schonfeld PhD a, Elizabeth K. Cahoon PhD a
doi : 10.1016/j.jaad.2024.01.084
Volume 91, Issue 1, July 2024, Pages 102-104
Psoriasis and non-Hodgkin’s lymphoma in a diverse sample of U.S. adults: a propensity matched case-control study
Michael J. Diaz BS a, Zaim Haq BS b, Jasmine T. Tran BS c, Parsa Abdi BS d, Kiran Motaparthi MD e, Jane M. Grant-Kels MD e f, Marjorie E. Montanez-Wiscovich MD, PhD e
doi : 10.1016/j.jaad.2024.02.040
Volume 91, Issue 1, July 2024, Pages 104-107
Use of biologic treatment in psoriasis patients with HIV: A systematic review
Siddhartha Sood HBSc a, Ryan Geng MSc a, Martin Heung b, Jensen Yeung MD c d e f, Asfandyar Mufti MD c d
doi : 10.1016/j.jaad.2024.02.042
Volume 91, Issue 1, July 2024, Pages 107-108
Cosmetic directors on ACGME program requirements: A cross-sectional survey
Kira Minkis MD, PhD a, Erik J. Stratman MD b, Victoria J. Shi BA c, Tanya Greywal MD d, Jenny C. Hu MD, MPH e, Kathleen C. Suozzi MD f, Sami K. Saikaly MD g, Arisa Ortiz MD h, Bianca Y. Kang MD c, Murad Alam MD, MSCI, MBA c i j k
doi : 10.1016/j.jaad.2024.01.085
Volume 91, Issue 1, July 2024, Pages 109-111
Improved survival outcomes for melanoma of unknown primary in the era of novel therapies: A population-based retrospective analysis
Connor J. Tupper BA a, Michaela C. Clausen BS b, Laura M. Cogua BS a, Peter T. Silberstein MD c
doi : 10.1016/j.jaad.2024.02.044
Volume 91, Issue 1, July 2024, Pages 111-113
Association between hidradenitis suppurativa and increased risk of venous thromboembolism: A multicenter retrospective cohort study
David Garate BS a, Katherine Woolridge MD b, Michael G. Wilkerson MD b, Ayezel Munoz Gonzalez MD b
doi : 10.1016/j.jaad.2024.03.002
Volume 91, Issue 1, July 2024, Pages 113-116
Projected burden of melanoma clinical surveillance in the United States
Natalie H. Matthews MD, MPhil a b, Judy Hamad MD, MPH a, James B. Henderson PhD c d, Martin A. Weinstock MD, PhD e f, Charles N. Ellis MD g h
doi : 10.1016/j.jaad.2024.03.003
Volume 91, Issue 1, July 2024, Pages 116-119
Low incidence of invasive fungal infections in a large observational cohort of patients initiating IL-17 or IL-23 inhibitor therapy, United States, 2016-2022
Nathan C. Bahr MD a, Kaitlin Benedict MPH b, Mitsuru Toda PhD b, Jeremy A.W. Gold MD b, Shari R. Lipner MD, PhD c
doi : 10.1016/j.jaad.2024.02.045
Volume 91, Issue 1, July 2024, Pages 119-122
Cost of hospitalization for care of children with epidermolysis bullosa in the US
Amar D. Desai MPH a, Amit Singal BA a, Sara Behbahani MD, MS b c, Yssra Soliman MD d, Elena B. Hawryluk MD, PhD e f
doi : 10.1016/j.jaad.2024.02.046
Volume 91, Issue 1, July 2024, Pages 122-125
Epidemiologic and clinical differences between early-onset and later-onset childhood vitiligo: A retrospective cohort study
Li Meiyun MS a, Xie Li PhD b, Liu Xiaoyi MS a, Deng Dan PhD a
doi : 10.1016/j.jaad.2024.02.047
Volume 91, Issue 1, July 2024, Pages 125-127
The financial burden of scalp cooling therapy: A nonprofit organization data analysis
Madison Novice BS a, Taylor Novice MD b, Molly Powers MD b, Kristen I. Lo Sicco MD c
doi : 10.1016/j.jaad.2024.02.049
Volume 91, Issue 1, July 2024, Pages 127-129
Retrospective analysis of multiple myeloma drug use in cutaneous toxicity of monoclonal gammopathy of undetermined significance
Emily R. Gordon BA a, Caroline Chen BA a, Oluwaseyi Adeuyan BS a, Brigit A. Lapolla BS b, Megan H. Trager MD b, Lauren M. Fahmy BS a, Celine M. Schreidah BS a, David A. Wetter MD c, Larisa J. Geskin MD a b
doi : 10.1016/j.jaad.2024.02.050
Volume 91, Issue 1, July 2024, Pages 129-130
Th2 response drives itch in dystrophic epidermolysis bullosa pruriginosa: A case-control study
Marieta Papanikolaou MBBS, PhD a, Leigh Nattkemper PhD b, Natashia Benzian-Olsson MSc a, Lu Liu PhD c, Alyson Guy c, Han Lu PhD d, Tendai Kadiyirire MRes, BSc a, Ping-Chen Hou MD e, Wilson Aala MSc f, Sonia Serrano BSc g, Rashida Pramanik BSc g, Nina Walters MSc a, Konstantina Dimitrakopoulou PhD g, Su Lwin MBBS, PhD a, Emily Kalfas a, Jose Satoc MSc h, Roman Laddach MRes a, Domenico Cozzetto PhD g, Bjorn Thomas MBBS, PhD i, Evangelia Kesidou PhD a…John A. McGrath MBBS, MD a
doi : 10.1016/j.jaad.2024.01.088
Volume 91, Issue 1, July 2024, Pages 130-133
Risk of systemic lymphoma in patients with cutaneous CD30+ lymphoproliferative disorders: A single center retrospective cohort analysis
Jennifer Chen MD, Abigail Martinez BS, Michi M. Shinohara MD
doi : 10.1016/j.jaad.2024.02.054
Volume 91, Issue 1, July 2024, Pages 134-135
Diagnostic utility of gingival biopsy for pemphigus vulgaris and mucosa membrane pemphigoid: A 10-year cohort study
Junjiang Liu MMed a, Can Hu MBBS a, Jing He MBBS a, Jingtian Mu MMed a, Shimeng Wang PhD a, Qi Han PhD b, Jia Li BS a, Mei Lin MMed a, Qinghong Gao PhD c, Fanglong Wu DDS, PhD a, Hongmei Zhou DDS, PhD a
doi : 10.1016/j.jaad.2024.03.005
Volume 91, Issue 1, July 2024, Pages 135-138
Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease
Mary Grace Hren BS a b, Sophie Guenin MSc a c, Saakshi Khattri MD a
doi : 10.1016/j.jaad.2024.03.007
Volume 91, Issue 1, July 2024, Pages 138-140
Attenuation of disease process following treatment with low-dose naltrexone in patients with frontal fibrosing alopecia and lichen planopilaris: A retrospective study
Selina M. Yossef BA, Joseph C. English III MD
doi : 10.1016/j.jaad.2024.03.010
Volume 91, Issue 1, July 2024, Pages 141-142
PIDASI and PIHASI: Scoring tools for assessment of postinflammatory hyperpigmentation
Michelle Lazar BS a, Shawn Shih MD b, Susruthi Rajanala MD a, Henriette De La Garza MD c, Kevin F. Kennedy MSc d, Neelam A. Vashi MD a
doi : 10.1016/j.jaad.2024.03.011
Volume 91, Issue 1, July 2024, Pages 142-144
Evaluation of the measurement properties and validation of the Skindex-16 among patients with acne
Ali Shields BS a b, Suephy C. Chen MD, MS c d, Manraj N. Kaur PhD e, Donna Rowen PhD, MSc f, Alison Layton MBChB g h, Diane Thiboutot MD i, Jerry Tan MD j, John S. Barbieri MD, MBA a
doi : 10.1016/j.jaad.2024.02.057
Volume 91, Issue 1, July 2024, Pages 144-146
Dermatoscopic features and potential pitfalls of artificial intelligence–based analysis of benign acral pigmented lesions in Black patients: A multicenter observational study
Mariela Mitre MD, PhD a b, Sharif Hosein BSc c, Andia Mitri MD c d e, Nicholas R. Kurtansky BSc c, Silvia E. Mancebo MD e, Maira Fonseca MD d e, Ashley Keyes Jacobs MD d e, Veronica Rotemberg MD, PhD c, Michael A. Marchetti MD c
doi : 10.1016/j.jaad.2024.02.058
Volume 91, Issue 1, July 2024, Pages 146-148
Histopathology and radiologic imaging for the confirmation of calciphylaxis in a diverse population: A retrospective cohort study
Michelle Toker BS a, Nicholas Forelli BS a, Olivia Wind MD a, Urmi Khanna MD a, Jose A. Jaller MD a, Sarah Fischer MD b, Edward Mardakhaev MD b, Benedict Wu DO, PhD a
doi : 10.1016/j.jaad.2024.03.012
Volume 91, Issue 1, July 2024, Pages 148-151
Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis
Lauren Banner BS a, Thomas Z. Rohan BS a, Rachel Zachian MD a b, Tyler Gross BS a, Henry Y. Yang BS a, Daniel Joffe BS a, Pierluigi Porcu MD c, Neda Nikbakht MD, PhD a
doi : 10.1016/j.jaad.2024.03.013
Volume 91, Issue 1, July 2024, Pages 151-153
Biologic immunomodulatory medications and autoimmune cytopenias: A cross-sectional analysis of a national surveillance database
Lorin A. Bibb MD a, Brian D. Adkins MD b, Laura D. Stephens MD c, Garrett S. Booth MD, MS d, Jeremy W. Jacobs MD, MHS e
doi : 10.1016/j.jaad.2024.03.014
Volume 91, Issue 1, July 2024, Pages 153-156
Characteristics and management of sclerosing skin diseases during immune checkpoint inhibitor therapy: An evidence-based review
Siddhartha Sood HBSc a, Ahmed Bagit BSc a, Dana Taghaddos BSc b, Aliyah King BA c, Khalad Maliyar MD d, Muskaan Sachdeva MD d, Asfandyar Mufti MD d e, Jensen Yeung MD d e f g
doi : 10.1016/j.jaad.2024.03.015
Volume 91, Issue 1, July 2024, Pages 156-158
Residency program unionization status and benefits: A national cross-sectional analysis of institutions with dermatology residencies
Ruhi Kanwar BS a b, Kaushik P. Venkatesh MBA, MPH a b, Ritika Manik BS a b, Sofia Milosavljevic BS a b, Vinod E. Nambudiri MD, MBA, EdM a
doi : 10.1016/j.jaad.2023.12.078
Volume 91, Issue 1, July 2024, Pages 158-161
Correlation of clinical and trichoscopy features with the degree of histologic inflammation in lichen planopilaris and frontal fibrosing alopecia in a cross-sectional study
Carolina Oliveira Costa Fechine MD, PhD a, Neusa Yurico Sakai Valente MD, PhD a, Ricardo Romiti MD, PhD a, Maryanne Makredes Senna MD b c
doi : 10.1016/j.jaad.2024.03.017
Volume 91, Issue 1, July 2024, Pages 161-163
Sexual dysfunction with 5-alpha-reductase inhibitor therapy for androgenetic alopecia: A global propensity score matched retrospective cohort study
Kyle C. Lauck MD a, Allison Limmer MD a, Peyton Harris BS b, Dario Kivelevitch MD a c
doi : 10.1016/j.jaad.2024.03.019
Volume 91, Issue 1, July 2024, Pages 163-166
Dermatologic findings associated with semaglutide use: A scoping review
Megan M. Tran BS a, Fatima N. Mirza MD, MPH b, Adrian C. Lee MS c, Hayley S. Goldbach MD b, Tiffany J. Libby MD b, Oliver J. Wisco DO b
doi : 10.1016/j.jaad.2024.03.021
Volume 91, Issue 1, July 2024, Pages 166-168
Elevation of creatine phosphokinase in moderate-to-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab: A systematic review and meta-analysis
Daud Manzar BHSc a, Emmanuel Suntres BHSc b, Nikhil Nair BSc a, Yash Patel PhD b, Mohannad Abu-Hilal MD a c
doi : 10.1016/j.jaad.2024.03.027
Volume 91, Issue 1, July 2024, Pages 168-169
Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis
James P. Pham MD a b c, Nana A.L. Rosenø MSc d, Gabriele Roccuzzo MD e, Ryan C. Saal BS f, Alexander Egeberg MD, PhD, DMSc d g, Hans C. Ring MD, PhD d, John W. Frew MBBS (Hons), MMed, MS, PhD a b c
doi : 10.1016/j.jaad.2024.03.028
Volume 91, Issue 1, July 2024, Pages 170-172
Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort
Yanmei Peng MD, PhD a b, Ashok V. Kumar MS a, Zhong Gu MS a, Nikhila Kosuru BS a, Jason A. Wampfler BS c, Pedro A. Reck dos Santos MD d, Nathan Y. Yu MD e, Jonathan D'Cunha MD, PhD d, Vinicius Ernani MD f, Collin M. Costello MD g, Ping Yang MD, PhD a
doi : 10.1016/j.jaad.2024.03.029
Volume 91, Issue 1, July 2024, Pages 172-175
Retrospective review of Mpox: Morphology and presentation in skin of color and sexual minorities
Richard W. Kim BS a, Ning C. McKenzie BA b, Kieron S. Leslie MBBS c
doi : 10.1016/j.jaad.2024.01.093
Volume 91, Issue 1, July 2024, Pages 175-177
Standardizing routine vaccination of dermatologists with occupational exposure to human papillomavirus in clinical settings
Katelyn J. Rypka BS a b, Ronda S. Farah MD a b, Matthew Mansh MD a
doi : 10.1016/j.jaad.2023.04.053
Volume 91, Issue 1, July 2024, Pages 178-179
Dermatology Images: Herpes simplex
Pelin Sagut MD, Dirk Elston MD
doi : 10.1016/j.jaad.2024.02.028
Volume 91, Issue 1, July 2024, Pages 180-183
Dermatology Images: Monkeypox
Andrés Grau-EchevarrÃa MD, Rodrigo Peñuelas-Leal MD, Carolina Labrandero-Hoyos MD, Javier Lorca-Spröhnle MD, Daniel Blaya-Imbernón MD, Malena Finello MD, Amparo Pérez-Ferriols MD, PhD, Pablo Hernández-Bel MD, PhD
doi : 10.1016/j.jaad.2024.02.048
Volume 91, Issue 1, July 2024, Pages 184-191
JAADÂ Game Changer: Etanercept therapy for toxic epidermal necrolysis
Robert T. Brodell MD
doi : 10.1016/j.jaad.2024.04.072
Volume 91, Issue 1, July 2024, Page 191
Commentary on: “Trends in price for topical corticosteroids from 2017 to 2021 and the opportunity for cost savings identifiable at the point of care: A retrospective cross-sectional study�
Michael C. Kwa MD a, Henry W. Lim MD b
doi : 10.1016/j.jaad.2024.02.016
Volume 91, Issue 1, July 2024, Pages 192-193
Herbal transparency in dermatology: Bridging care in Hispanic communities
Alexis Arza BS a, Jules B. Lipoff MD b
doi : 10.1016/j.jaad.2024.03.006
Volume 91, Issue 1, July 2024, Pages 194-196
Ethics of providing elective cosmetic care at discounted-cost and free clinics
Aneesh Agarwal MBA a, Samir Kamat BA a, Jacob Appel MD, JD, MPH a, Benjamin Stoff MD, MA b c
doi : 10.1016/j.jaad.2023.05.084
Volume 91, Issue 1, July 2024, Pages 197-198
Ethical concerns regarding environmental impact of American Academy of Dermatology meeting samples
Alana L. Ferreira BA a, Jeromy W. Gotschall BA a, Temitayo A. Ogunleye MD a, Jane M. Grant-Kels MD b c
doi : 10.1016/j.jaad.2023.06.017
Volume 91, Issue 1, July 2024, Pages 199-200
Beyond JAAD July 2024
Andrew Bronin MD
doi : 10.1016/j.jaad.2024.04.003
Volume 91, Issue 1, July 2024, Pages 201-204
Ultraviolet-induced fluorescence dermoscopy aids in distinguishing scarring and nonscarring alopecia: Enhancing Identification of Hair Follicle Openings: The Potential of Ultraviolet-induced Fluorescence Dermoscopy in Hair Loss Diagnosis
Xiangqian Li MD, Cheng Zhou MD
doi : 10.1016/j.jaad.2024.01.077
Volume 91, Issue 1, July 2024, Pages e1-e2
Povidone iodine gel use as a conductive and antiseptic in ultrasound-guided invasive procedures
Pedro Jose Navarro-Guillamón MD a, Maria Valencia-Serrano MD b, Jorge Alonso Suarez-Perez PhD a c, Enrique Herrera-Acosta PhD a c
doi : 10.1016/j.jaad.2024.01.087
Volume 91, Issue 1, July 2024, Pages e3-e4
A new method to optimize tourniquet during first toenail surgery
Luis Jiménez-Briones MD, Noelia Medrano MartÃnez MD, MarÃa Córdoba GarcÃa-Rayo MD, Daniel VÃrseda González MD, Enrique RodrÃguez-Lomba MD, PhD
doi : 10.1016/j.jaad.2024.01.074
Volume 91, Issue 1, July 2024, Pages e5-e6
Taking a multiview photograph with a mirror
Bernard M.H. Liang BDS, MEng
doi : 10.1016/j.jaad.2023.12.035
Volume 91, Issue 1, July 2024, Pages e7-e8
Response to Desai et al, “Response to ‘Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study’�
Michael Ong BS a, Shari R. Lipner MD, PhD b
doi : 10.1016/j.jaad.2024.02.055
Volume 91, Issue 1, July 2024, Pages e9-e10
Response to “Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: A retrospective study�
Deesha Desai BS a b, Ambika Nohria BA b, Michelle Sikora BS b c, Soutrik Mandal PhD d, Jerry Shapiro MD b, Avrom S. Caplan MD b, Michael Garshick MD b e, Kristen Lo Sicco MD b
doi : 10.1016/j.jaad.2024.01.089
Volume 91, Issue 1, July 2024, Pages e11-e12
Cost and access considerations for magnetic resonance imaging screening of infants with congenital melanocytic nevi: Authors' response to correspondence
Holly Neale MD a b, Isabella Plumptre MBBS a, Leah Belazarian MD a c, Karen Wiss MD a c, Elena B. Hawryluk MD, PhD b d e
doi : 10.1016/j.jaad.2024.02.056
Volume 91, Issue 1, July 2024, Page e13
Response to Neale et al., “Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi�
Arunachalam Narayanan MD, DNB, PDCC
doi : 10.1016/j.jaad.2024.01.090
Volume 91, Issue 1, July 2024, Pages e12-e13
Peter J. Lynch 1936-2024. An obituary
Sergei A. Grando MD, PhD, DSc a, Maria Hordinsky MD b, Elizabeth Edwards MD c, Christopher B. Zachary MD a
doi : 10.1016/j.jaad.2024.03.023
Volume 91, Issue 1, July 2024, Pages e14-e15
Pediatric Dermatology in Skin of Color: A Practical Guide
Mark J. Siegel MD
doi : 10.1016/j.jaad.2024.02.006
Volume 91, Issue 1, July 2024, Page e16
July 2024 iotaderma (#365)
Robert I. Rudolph MD, FACP
doi : 10.1016/j.jaad.2024.01.006
Volume 91, Issue 1, July 2024, Page e17
